Quality Systems and Risk Management Approaches for Networked Drug Development David A. Moyer VP, Regulatory Compliance Programs Fulcrum Pharma Developments,
SUSAN BECK-FRAZIER SUSAN MORRISSEY KRISTEN SPRINGER DREYFUS ALEX SENIOR 2014 Assessment Review Committees Training Sessions 1.
SUSAN BECK-FRAZIER SUSAN MORRISSEY KRISTEN SPRINGER DREYFUS ALEX SENIOR 2013 Assessment Review Committees Training Sessions 1.
Assessment Review Committees Training Sessions
